National Cancer Institute

Investments by market, targeted sectors and preferred funding rounds

Name - National Cancer Institute
Web -
Description -
Investor Type -
Preferred rounds -
Location

Investments by industry

biotech - 50%
healthtech - 50%

Number of investments: 2

National Cancer Institute invested in Elicio Therapeutics during a round worth $73,000,000 - 2/17/2021
National Cancer Institute invested in Outcomes4Me during a round worth $4,700,000 - 11/18/2020